Acil Serviste Ablasyon Öncesi Supraventriküler Taşikardi Yönetiminde Kardiyoversiyon: Olgu Sunumu

Yazarlar

Canan Akman

Özet

Supraventriküler taşikardi (SVT), anormal hızlı bir kalp ritmidir. Paroksismal supraventriküler taşikardi, SVT’nin en sık karşılaşılan türüdür. Uzun vadede kalbin yapısal değişim geçirmesine neden olabilmektedir. Tanı; klinik, elektrokardiyografi (EKG) ve elektrofizyolojik değerlendirmeyi kapsamaktadır. Güncel tedavi yaklaşımları farmakolojik tedavi veya aritmojenik odağın kateter ablasyonu ile ortadan kaldırılmasını içermektedir. Kateter ablasyonu, deneyimli merkezlerde gözlemlenen etkinliği ve genel güvenliği nedeniyle SVT yönetiminde giderek daha fazla kullanılmaktadır. Aritmi sırasında hemodinamik instabilite yaşayan hastalar için birincil tedavi olarak önerilmekle birlikte atriyoventriküler (AV) düğüm bloke edici ajanlara dirençli aritmileri olan hastalar için de bir seçenektir.

 

Referanslar

Nasir M, Sturts A, Sturts A. Common Types of Supraventricular Tachycardia: Diagnosis and Management. Am Fam Physician. 2023;107(6):631-641.

Pourmand A, Checkeye H, Varghese B,et al. The Role of Troponin Testing in Patients with Supraventricular Tachycardia, Systematic Review and Meta-Analysis. J Emerg Med. 2024;67(5):e402-e413. doi: 10.1016/j.jemermed.2024.05.010.

Krisai P, Sticherling C. Supraventricular tachycardia. Cardiovasc. Med.2021, 24(4), w02167;https://doi.org/10.4414/cvm.2021.02167.

Gamberini L, Moro F, Dallari C,et al. Prehospital diagnosis and management of supraventricular tachycardia – a scoping review. Scand J Trauma Resusc Emerg Med (2026). https://doi.org/10.1186/s13049-026-01583-8

Kamareddine M, Keramati AR. Advances in Antiarrhythmic Drug Therapy: Pharmacologic Management of Supraventricular Tachycardia. Card Electrophysiol Clin. 2026;18(1):45-56. doi: 10.1016/j.ccep.2025.10.002.

Barzin AH, Paulus R, Arabindoo KK. Supraventricular tachycardia. October 19, 2020. Updated September 16, 2022. Accessed April 1, 2023. https://www.essentialevidenceplus.com/content/eee/17

Helton MR. Diagnosis and management of common types of supraventricular tachycardia. Am Fam Physician. 2015;92(9):793-800.

Katritsis DG. Atrioventricular nodal reentrant tachycardia. In: Camm JA, Lüscher TF, Maurer G, eds. The ESC Textbook of Cardiovascular Medicine. 3rd ed. Oxford University; 2018.

Kotadia ID, Williams SE, O'Neill M. Supraventricular tachycardia: An overview of diagnosis and management. Clin Med (Lond).2020 Jan;20(1):43-47. doi: 10.7861/clinmed.cme.20.1.3.

Jabbour F, Horenstein MS, Grossman SA. Atrioventricular Reciprocating Tachycardia. 2024 Feb 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. European Heart Journal (2019) 00, 165. doi:10.1093/eurheartj/ehz467.

Goyal A, Singh B, Chhabra L, Singhal M. Synchronized Electrical Cardioversion. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.

Ćwiertnia M, Dutka M, Białoń P,et al. What Mistakes Can Be Made When Performing the Electrical Cardioversion Procedure?-Analysis of Emergency Medical Team Performance during the Championships in Emergency Medicine. Healthcare (Basel). 2024;12(17):1724.doi: 10.3390/healthcare12171724.

Forkmann M, Schwab C, Busch S. Catheter ablation of supraventricular tachycardia. Herzschrittmacherther Elektrophysiol. 2019;30(4):336-342. doi: 10.1007/s00399-019-00654-x.

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the Management of Adult Patients with Supraventricular Tachycardia: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol., 67 (2016), pp. e27-e115. doi:10.1016/j.jacc.2015.08.856.

Chew DS, Sacks NC, Emden MR, et al. Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study. Int J Cardiol.2024; 403:131831. doi: 10.1016/j.ijcard.2024.131831.

Pourmand A, Checkeye H, Varghese B, et al. The Role of Troponin Testing in Patients with Supraventricular Tachycardia, Systematic Review and Meta-Analysis. J Emerg Med. 2024; 67(5): e402–e413. https://doi.org/10.1016/j.jemermed.2024.05.010.

Fernando H, Adams N, Mitra B. Investigations for the assess- ment of adult patients presenting to the emergency department with supraventricular tachycardia. World J Emerg Med 2020;11(1):54–9. doi: 10.5847/wjem.j.1920-8642.2020.01.008 .

Lan Q, Han B, Wu F, et al. Modified Valsalva maneuver for treatment of supraventricular tachycardias: a meta-analysis. Am J Emerg Med. 2021;50:507-512.

Smith GD, Fry MM, Taylor D, et al. Effectiveness of the Valsalva manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev. 2015(2):CD009502.

Alabed S, Sabouni A, Providencia R, et al. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. Cochrane Database Syst Rev. 2017(10):CD005154.

Lei M, Wu L, Terrar DA, et al. Modernized classification of cardiac anti-arrhythmic drugs [published correction appears in Circulation. 2019; 139(13): e635]. Circulation. 2018;138(17):1879-1896.

Sayfalar

203-208

Yayınlanan

20 Ağustos 2026

Lisans

Lisans